Rationale and Comments

There is convincing evidence that PSA-based screening leads to substantial overdiagnosis of prostate tumors. Many tumors will not harm patients, while the risks of treatment are significant. Physicians should not offer or order PSA screening unless they are prepared to engage in shared decision making that enables an informed choice by patients.

Sponsoring Organizations

• American Academy of Family Physicians

Sources

• U.S. Preventive Services Task Force

Disciplines

• Oncologic
• Preventive Medicine
• Urologic

References

• American Academy of Family Physicians. Prostate cancer [Internet]. Leawood (KS): American Academy of Family Physicians; 2012 [cited 2013 Jul 23]. Available from: http://www.aafp.org/patient-care/clinical-recommendations/all/prostate-cancer.html.
  
• U.S. Preventive Services Task Force. Screening for prostate cancer. Rockville (MD): U.S. Preventive Services Task Force. 2012 May. 16 p.